Although we take the Government’s state of emergency seriously, in order not to pause our first cancer screening test N-NOSE completely, we continue the analysis in our analysis center and three R&D centers while taking necessary steps to prevent infection.
To support our employees to cope with the situation, we have decided to reward them with lump-sum payments (JPY 30,000 per employee).
We will continue to focus on our efforts to expand N-NOSE tests so that we can provide it for as many people as possible.
Paper was in "International Journal of Molecular Sciences".For more details→☆2020.04.20
Hirotsu Bio Science has decided to apply measures based on government policies and action plans.We have received a request from some of the clin . . .2020.02.28
In order to respond to the spread of the new coronavirus infection, Hirotsu Bio Science Inc. has decided to implement stagger work hours for the . . .2020.02.28